Clinical Trials Directory

Trials / Unknown

UnknownNCT04008667

The Effect of Acupoint Application on Postoperative Ileus

The Effect of Acupoint Application on Postoperative Ileus: a Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
540 (estimated)
Sponsor
li xiong · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to verify the therapeutical effect and mechanism of acupoint application on postoperative ileus.

Detailed description

Postoperative ileus (POI) is a common disorder of gastrointestinal motility characterized by abdominal distension, nausea, vomiting and delayed passage of flatus or stool, which develops after every abdominal surgical procedure. POI increases risk of developing postoperative complications, decreases the bed turnover rate and prolongs the average duration of hospitalization, increasing the expense of both patients and hospitals. Although the Pathophysiological mechanism of POI remains unclear, recent researches suggests the inflammatory responses after surgery might be responsible for the gastrointestinal motility disorder. Acupoint application is a traditional chinese intervention which has been used in treating gastrointestinal motility disorder resulted from other causes. In this study, we aims to verify the therapeutical effect and mechanism of acupoint application on postoperative ileus.

Conditions

Interventions

TypeNameDescription
OTHERAcupoint applicationAcupoint application: The patients start using the acupoint application on the umbilical Shenque point in 2 hours after surgery, 1 or 2 times a day, lasting 5 days.
OTHERFake acupoint applicationFake acupoint application: The patients start using the fake acupoint application on the umbilical Shenque point in 2 hours after surgery, 1 or 2 times a day, lasting 5 days.

Timeline

Start date
2019-07-01
Primary completion
2021-07-01
Completion
2021-07-01
First posted
2019-07-05
Last updated
2019-07-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04008667. Inclusion in this directory is not an endorsement.